Celeste

Quick links to important sections

Celeste

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Celeste

Celeste is a prescription-only medication whose active ingredient is Tadalafil, a synthetic small molecule used primarily to address conditions related to compromised blood flow and smooth muscle tension. It is a single-ingredient drug, classified as a Phosphodiesterase type 5 (PDE5) inhibitor, and is administered as an oral tablet.


Quick Facts: Tadalafil (Active Ingredient)

Property Description
Active ingredient Tadalafil
Form Oral tablet (Film-coated)
Pharmacological class Phosphodiesterase type 5 (PDE5) inhibitor
General purpose Improving function related to localized blood flow and muscle relaxation
Origin Synthetic compound

What Type of Medicine is Celeste (Tadalafil)?

Celeste is a single-ingredient pharmaceutical preparation containing Tadalafil, which is chemically distinct from other agents in the same class, such as Sildenafil. It is classified as a Phosphodiesterase type 5 (PDE5) inhibitor, a group of drugs supported by extensive pharmacological studies. The Tadalafil compound is synthetic in origin and is formulated for oral delivery as a solid tablet. A significant differentiating factor is Tadalafil's long half-life, which provides an extended duration of therapeutic effect—a property clinically recognized for offering increased flexibility in patient management.


What is the General Purpose of Celeste?

The general purpose of Celeste is to improve function in the body's vascular and smooth muscle systems where increased blood flow is therapeutically beneficial. Its pharmacological mechanism, which confirms Tadalafil acts as a potent and selective PDE5 inhibitor, is clinically used to address underlying physiological barriers. This includes improving function related to erectile difficulties, managing symptoms of an enlarged prostate, or reducing elevated pressure in the pulmonary arteries. Tadalafil's unique action profile allows it to be used in therapeutic scenarios requiring both vascular support and smooth muscle relaxation over an extended period.

Regulatory References

  1. Tadalafil - StatPearls - NCBI Bookshelf

What side effects are possible with Celeste?

Possible Side Effects and Safety Information

The officially documented safety profile for Celeste (Tadalafil) is structured by frequency and the body system affected, based strictly on authoritative regulatory sources like the EMA and FDA. All reported adverse reactions fall into four general categories: Very Common, Common, Uncommon, and Rare.


Key Adverse Reaction Categories

Classification Examples of Reactions (by SOC)
Common (ge 1/100 to < 1/10) Headache (Nervous System), Dyspepsia and Gastroesophageal Reflux (Gastrointestinal), Back Pain and Myalgia (Musculoskeletal), Flushing and Nasal Congestion (Vascular).
Uncommon (ge 1/1,000 to < 1/100) Hypersensitivity reactions, Tachycardia, Hypotension, Blurred Vision, Epistaxis, and Chest Pain.

Serious Adverse Reactions

The regulatory documents specify several rare but clinically significant adverse events. These include Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), which can result in sudden visual loss, Sudden Decrease or Loss of Hearing, and Prolonged Erection (Priapism). Other rare events reported include Myocardial Infarction (heart attack), Stroke, and severe skin reactions like Stevens-Johnson Syndrome.


Safety Restrictions and Special Populations

Celeste is contraindicated in patients who are using any form of organic nitrate. Caution is required in patients with pre-existing cardiovascular risk factors or anatomical deformation of the penis. Use is generally not recommended in patients with severe hepatic impairment or severe renal impairment; specific dose limitations and monitoring apply to patients with moderate impairment. The frequency of common effects like headache and muscle aches is documented to be more common at higher doses and may be limited to the start of daily treatment.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Celeste (Tadalafil) is officially documented in regulatory sources as an exaggeration of common adverse events seen at therapeutic doses. Clinical signs may include severe headache, dyspepsia, and hypotension (a substantial drop in blood pressure), which is a key manifestation resulting from the drug's vasodilatory properties. Doses significantly higher than those prescribed have been reported to increase the frequency of these effects.

Immediate Emergency Action is Required

Certain manifestations are explicitly classified by regulatory authorities as time-critical complications requiring urgent intervention:

  • Priapism: An erection lasting more than four hours requires immediate medical attention or emergency treatment to prevent permanent tissue damage.
  • Sudden Vision or Hearing Loss: The onset of sudden loss of vision or sudden decrease or loss of hearing mandates that use be stopped and immediate medical care be sought.

In all suspected cases of overdose, official guidance instructs contacting emergency services or a Poison Control Center. No specific antidote is known, and the management strategy is to provide symptomatic and supportive treatment. Furthermore, hemodialysis is not expected to influence clearance. Patients with severe renal or hepatic impairment are noted in regulatory information as having an increased risk of exposure and subsequent toxicity due to impaired drug clearance.

Therapeutic Uses of Celeste

What Celeste Treats: Main Uses and Benefits

Celeste (Tadalafil) is utilized across several therapeutic domains to provide functional support and symptomatic relief, and is applied across domains where additional symptomatic support is needed. This medication is commonly used to treat Erectile Dysfunction (ED), the signs and symptoms of Benign Prostatic Hyperplasia (BPH), and Pulmonary Arterial Hypertension (PAH).


Easing Functional Impairment in Sexual Activity

This domain addresses symptoms related to physical discomfort and vascular responsiveness impairment, where compromised local blood flow results in the inability to achieve or maintain sufficient penile rigidity. Celeste may assist with the ability to achieve and sustain sexual activity, and contributes to maintaining functional stability when symptoms are more noticeable.


Symptomatic Relief for Prostate and Pulmonary Conditions

Celeste is applied across conditions characterized by periods of heightened symptoms. It is used to help manage the bothersome Lower Urinary Tract Symptoms (LUTS) that arise from an enlarged prostate (BPH), such as increased frequency, urgency, and a weak stream. It provides support that helps ease the overall symptom burden of these manifestations and helps improve day-to-day comfort during symptomatic periods. Furthermore, the medication may be part of symptomatic management for Pulmonary Arterial Hypertension (PAH), which supports the patient during difficult episodes and helps maintain functional stability for affected adults.


Quick Fact: Symptomatic Support
Used for managing Symptoms that interfere with daily functioning and create noticeable physiological strain (e.g., LUTS, difficulty achieving/sustaining function, reduced exercise capacity).
Typical Context Conditions involving episodic or chronic functional stress relevant when supportive symptom management is appropriate.
Contributes to easing the symptom load Provides support that helps ease the overall symptom burden and assists with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Celeste?

Eligibility to use Celeste (Tadalafil) is strictly defined by regulatory authorities and depends on a patient’s concurrent medications, medical history, and specific conditions. This information is derived from official prescribing labels and determines who is formally approved to use the medicine and who is prohibited.

Absolute Contraindications

Celeste must not be used by patients who fall into the following non-eligible populations:

Non-Eligible Population Restriction Context
Nitrate Users Patients taking any form of organic nitrate (e.g., nitroglycerin), regularly or intermittently, due to the risk of severe hypotension.
GC Stimulator Users Patients using Guanylate Cyclase (GC) Stimulators (e.g., Riociguat).
Prior Ocular History Patients with a history of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).
Recent Cardiac Events Patients who have experienced a stroke within the last 6 months or a heart attack within the last 90 days (EMA restriction).

Age and Condition Restrictions

Celeste is primarily indicated for use in adult men for conditions like ED and BPH. For Pulmonary Arterial Hypertension (PAH), it is approved for adults and conditionally for pediatric patients aged 2 to 17. The medicine is not recommended for patients with severe hepatic impairment (Child-Pugh Class C) or those with severe renal impairment on daily dosing, as safety has not been fully established in these groups. Caution is advised for older adults due to potential increased sensitivity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Celeste (Tadalafil) is defined by documented pharmacokinetic and pharmacodynamic constraints. Co-administration of Celeste is contraindicated with any form of organic nitrate due to the risk of severe, additive hypotensive effects. The use of Guanylate Cyclase (GC) stimulators such as Riociguat is also formally contraindicated.

Interaction Type Interacting Agent Examples Official Regulatory Outcome
Contraindication Organic Nitrates, GC Stimulators Prohibited due to documented severe hypotensive risk.
Pharmacokinetic CYP3A4 Inhibitors (e.g., Ketoconazole) Increases Tadalafil exposure (AUC) significantly.
Pharmacokinetic CYP3A4 Inducers (e.g., Rifampin) Decreases Tadalafil exposure (AUC).
Pharmacodynamic Alpha-Blockers (e.g., Doxazosin), Antihypertensives, Alcohol (substantial amounts) May potentiate blood pressure lowering effects.

Tadalafil is predominantly metabolized by the CYP3A4 enzyme, which governs interactions with substances that inhibit or induce this pathway. Grapefruit juice is expected to increase Tadalafil plasma concentrations via CYP3A4 inhibition. A critical timing-based restriction states that a minimum of 48 hours must pass after the last dose before organic nitrates may be administered. Furthermore, use is generally restricted in patients with severe renal impairment due to a documented increase in Tadalafil exposure. Co-administration with other PDE5 inhibitors is restricted based on lack of safety data.

Mechanism of Action

How Celeste Works

The mechanism of Celeste, containing Tadalafil, involves selective enzyme inhibition and modulation of a biological cascade that regulates smooth muscle contractility and local vascular dynamics.

The active ingredient, Tadalafil, acts as a selective competitive inhibitor of the Phosphodiesterase type 5 (PDE5) enzyme, which is abundant in specific smooth muscle tissues. By physically blocking PDE5's active site, the drug prevents the breakdown of the key cellular messenger cyclic Guanosine Monophosphate (cGMP). This molecular action results in the preservation and prolongation of the smooth muscle relaxation signal within the cell.

The inhibition of PDE5 increases the effect of the natural Nitric Oxide (NO)-cGMP signaling cascade. Elevated cGMP levels activate protein kinase G, which triggers a cascade that reduces intracellular calcium, leading directly to the relaxation of the local smooth muscle fibers. This physiological change results in reduced vascular resistance, which alters local hemodynamics in the tissue where the mechanism is engaged.

The mechanism is conditional; Tadalafil is a signal potentiator and does not initiate the physiological effect itself. Its action is dependent upon the prior, natural release of Nitric Oxide from nerve endings or endothelial cells. This mechanism dictates that the drug enhances the relaxation response only when a biological stimulus has already triggered the pathway.

Dosage and Administration Information

Celeste is administered orally as a film-coated tablet and must be swallowed whole. The medicine may be taken with or without food across all approved indications. Usage is generally defined by the therapeutic context, leading to two distinct frequency patterns:


Administration Patterns

  • Once-Daily Use: This regimen is employed for continuous management, such as in Benign Prostatic Hyperplasia (BPH) or Pulmonary Arterial Hypertension (PAH), and requires the medicine to be taken at approximately the same time each day. Doses vary by condition, ranging from 5 mg for BPH to a fixed 40 mg for PAH.
  • As-Needed Use: This pattern is utilized for certain indications and allows for intake up to a maximum of once per day. When used as needed, the tablet should be administered at least 30 minutes prior to anticipated activity.

Procedural Constraints

Administration instructions also include procedural constraints related to physiological status. No dose adjustment is typically required for older adults (over 65 years). However, official guidelines specify mandatory reductions or advise against use in patients with severe renal or hepatic impairment.

If a dose in a once-daily regimen is missed, an extra dose should not be taken; rather, the patient should resume the regular schedule the following day. This structural approach ensures the medicine is used within the established parameters.

Recent Clinical Evidence

Research evidence / Overview of Studies for Celeste


Evidence for use in Erectile Dysfunction (ED)

Celeste (Tadalafil) was studied for Erectile Dysfunction (ED), and research examined functional measures in numerous clinical trials. The primary evidence base consists of short-term, randomized, double-blind, placebo-controlled trials (RCTs). These studies monitored adult men with varying degrees of ED severity, including those with other common health conditions such as diabetes and hypertension. The research focused on outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level.

The findings describe patterns observed in the studies where functional scores were monitored in the treatment groups over observation periods compared to the placebo groups. Outcomes and observations are not well characterized for follow-up periods exceeding two years, and existing research provides limited information for specific patient groups who were excluded from the pivotal trials due to severe cardiovascular conditions.


Evidence for use in Benign Prostatic Hyperplasia (BPH) Symptoms

Research on the use of Celeste for Lower Urinary Tract Symptoms (LUTS) associated with an enlarged prostate (BPH) is based on randomized, placebo-controlled trials. These studies focused on a once-daily regimen, examining outcomes related to physical discomfort using standardized scoring systems, such as the International Prostate Symptom Score (IPSS). Studies reported how symptoms evolved in the observed populations using the IPSS total and Quality of Life (QoL) scores across the treatment groups over observation periods of up to six months.

Data showing the sustained functional support on symptom scores beyond six months is limited in the controlled trials. Furthermore, the available studies provide insufficient data to characterize the outcomes when the medicine is used in combination with all types of alpha-blockers.


Key Limitations and Areas of Research Uncertainty

The research on Celeste, while based on many controlled trials, has defined limitations. One key limitation is that the results apply only to the populations studied and do not guarantee personal outcomes. The follow-up durations were limited for core efficacy endpoints, meaning long-term effects are not fully established for all outcomes. Additionally, the comparative evidence is lacking for certain combination therapies, and data for pediatric populations remain insufficient.

Key Studies & References

  1. Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials - Translational Andrology and Urology
  2. Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis - Frontiers
  3. Does Tadalafil Improve Exercise Capacitance in Patients over 12 Years Old with Pulmonary Hypertension? - DigitalCommons@PCOM

Frequently Asked Questions (FAQ)

Common questions about Celeste (FAQ)

Q: What makes Celeste different from other medications in the same class?

Official product information describes Tadalafil, the active ingredient, as chemically distinct from other medicines in the same class. A key difference is its long half-life which is documented to be approximately 17.5 hours in healthy subjects. This extended half-life provides the pharmacological basis for its extended duration of effect.

Q: Is it normal to experience stomach upset when first taking Celeste?

Official safety documentation lists dyspepsia, which is the medical term for indigestion or stomach upset, as a common adverse event. Gastroesophageal reflux is also reported commonly. Regulatory data indicates this effect may be more frequent at the start of daily treatment.

Q: Does Celeste interact with common over-the-counter pain relievers?

Regulatory labeling explicitly discusses interactions with prescription medications and certain non-prescription drugs like Aspirin. However, specific clinical guidance on common pain relievers like Ibuprofen or Acetaminophen is not uniformly detailed as a formal restriction. Official guidance emphasizes the importance of informing a healthcare provider about all over-the-counter medicines used.

Q: Are there any specific foods or beverages to avoid while taking Celeste?

Official product information indicates that grapefruit and grapefruit juice are expected to increase the concentration of Tadalafil in the body. Additionally, consuming substantial amounts of alcohol may potentiate, or increase, the medicine's blood pressure-lowering effects.

Q: Are there official guidelines for using Celeste in pediatric patients?

Tadalafil is approved for conditional use in pediatric patients aged 2 to 17 years, specifically for the treatment of Pulmonary Arterial Hypertension (PAH). The use and dose for this condition require guidance from a specialist.

Q: Does Celeste affect blood pressure or heart rate?

The medicine has known vasodilatory properties, meaning it can cause blood vessels to relax, which may result in a transient decrease in blood pressure (hypotension). Tachycardia (an increased heart rate) is also documented as an uncommon adverse reaction in safety information.

Q: What is the typical duration of action for a single dose of Celeste?

Due to the active ingredient's long half-life, the medicine provides an extended therapeutic window. The pharmacological window of the medicine is understood to extend up to 36 hours after taking a single dose.

Q: Does Celeste lose its effectiveness over time with continued use?

Official research data, such as that for the use of Tadalafil in BPH symptoms, has limited data showing sustained functional support beyond six months in controlled trials. Therefore, the long-term effects of effectiveness for all outcomes are not fully established based on the core clinical evidence.

Q: What is known about the results of the key clinical trials for Celeste?

Studies focused on outcomes related to physical comfort and daily functioning. The clinical trial findings describe that Tadalafil improved functional scores for conditions like ED and BPH symptoms in the treatment groups compared to the placebo groups over the observation periods.

Q: Why was Celeste given a specific regulatory warning (e.g., a Boxed Warning)?

The regulatory labeling for Tadalafil does not include an explicit Boxed Warning for all approved uses. However, the product carries strong warnings and precautions for very serious but rare events, such as sudden visual loss (Non-arteritic Anterior Ischemic Optic Neuropathy, or NAION) and prolonged erection (Priapism).

Q: What is the typical patient experience when first starting Celeste?

Common initial effects may include headache, back pain, and muscle aches (myalgia). Official documentation indicates that the frequency of these common effects may be limited to the start of daily treatment.

Q: How long has Celeste been available on the market?

The active ingredient in Celeste, Tadalafil, was first brought to market under the brand name Cialis in 2003.

Q: How does Celeste compare to a similar drug, Drug X?

Regulatory documents confine their descriptions to the properties of Tadalafil itself. They note that its chemical structure and half-life are distinct from other PDE5 inhibitors, but direct comparison of efficacy or superiority is not provided.

Q: Is Celeste classified as a controlled substance?

No, Tadalafil is not listed as a federally controlled substance by the DEA (Drug Enforcement Administration). This classification indicates the medicine has a low potential for abuse, dependence, or withdrawal.

Q: Does taking Celeste affect my sleep schedule?

Official safety documentation does not list insomnia or other sleep disturbances among the most common, uncommon, or serious adverse reactions in the primary regulatory tables.

Q: Will Celeste make me feel tired or drowsy?

Somnolence (drowsiness) is not typically listed as a common adverse reaction. However, postmarketing reports include general tiredness (fatigue) and dizziness, which may occur.

Q: Can Celeste be taken at the same time as my daily vitamins?

The regulatory product labeling does not list interactions with standard multivitamin components. General guidance emphasizes that patients should always inform their healthcare provider of all non-prescription items and supplements they take.

Q: Does Celeste have known interactions with herbal or dietary supplements?

Official sources note that St. John's wort, a non-prescription herbal product, is known to interact with Tadalafil. St. John's wort is associated with reducing the concentration of the medicine in the body.

Q: Can Celeste be used by pregnant or breastfeeding individuals?

Tadalafil is generally not recommended during pregnancy unless a specialist deems its use necessary for a life-threatening condition, such as severe Pulmonary Arterial Hypertension (PAH). Regulatory information suggests that use during breastfeeding is typically advised against.

Q: What is the half-life of Celeste?

The half-life is the time it takes for the concentration of the drug in the body to be reduced by half. According to official pharmacokinetic studies in healthy subjects, the mean half-life of Tadalafil is 17.5 hours.

Q: Is there a generic version of Celeste currently available?

Yes, the patent for the brand name has expired in many regions, allowing generic drug manufacturers to supply the active ingredient, Tadalafil.

Q: What is the official difference between the brand name Celeste and the generic equivalent?

The generic version contains the same active ingredient (Tadalafil) as the brand-name product. Regulatory agencies require that generics meet the same strict quality, strength, and performance standards as the original drug.

Q: Does Celeste cause a feeling of dependence or withdrawal if stopped?

No, Tadalafil is not classified as a federally controlled substance by the DEA. This is a regulatory indication that the medicine has a low potential for abuse, dependence, or withdrawal effects.

How should Celeste be stored and disposed of?

How to Store and Dispose of Celeste (Tadalafil)

Celeste must be stored according to official regulatory specifications to maintain its labeled stability and quality.

Storage Requirements

Condition Regulatory Requirement
Temperature Do not store above 30°C (86°F). Keep from freezing and excessive heat.
Environment Store in the original package to protect from moisture and direct light.
Safety Keep the medication out of the reach of children.

Disposal Instructions

Any unused or expired product must be disposed of in accordance with local requirements. The preferred method is using a community drug take-back program. If this is unavailable, the tablets should be mixed with an undesirable substance, placed in a sealed container, and thrown into the household trash. Do not flush Celeste down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Celeste found in:

A-Z Index: